Contemporary Management of Raynaud's Phenomenon and Digital Ischaemic Complications

Ariane L. Herrick

Disclosures

Curr Opin Rheumatol. 2011;23(6):555-561. 

In This Article

Conclusion

Key recent advances have been the increased understanding of the role of phosphodiesterase inhibitors and of ET-1 receptor antagonists (both of which are now widely used in patients with severe disease), the revisiting of topical GTN, and the increased recognition that optimal management of patients with ischaemic complications includes close liaison with surgical colleagues: timely surgical debridement or digital sympathectomy may save a digit. These advances have been driven by increased networking of clinicians internationally, facilitating much larger clinical trials than have previously been possible, and offering the potential of successfully addressing the remaining unanswered questions.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....